SCHEDULE 13G/A

Statement of Beneficial Ownership

abrdn Life Sciences Investors Filed 2026-10-14 Acc 0001445546-26-007613

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-10-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-03-06 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)